136 related articles for article (PubMed ID: 7949110)
1. Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation.
Ho AD; Maruyama M; Maghazachi A; Mason JR; Glück S; Corringham RE
Blood; 1994 Nov; 84(10):3550-7. PubMed ID: 7949110
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.
Burns LJ; Weisdorf DJ; DeFor TE; Repka TL; Ogle KM; Hummer C; Miller JS
Exp Hematol; 2000 Jan; 28(1):96-103. PubMed ID: 10658681
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery.
Testa U; Martucci R; Rutella S; Scambia G; Sica S; Benedetti Panici P; Pierelli L; Menichella G; Leone G; Mancuso S
Blood; 1994 Nov; 84(10):3532-9. PubMed ID: 7949108
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
6. Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.
de Gast GC; Vyth-Dreese FA; Nooijen W; van den Bogaard CJ; Sein J; Holtkamp MM; Linthorst GA; Baars JW; Schornagel JH; Rodenhuis S
J Clin Oncol; 2002 Jan; 20(1):58-64. PubMed ID: 11773154
[TBL] [Abstract][Full Text] [Related]
7. Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation.
Fattorossi A; Battaglia A; Pierelli L; Malinconico P; Andreocci L; Perillo A; Ferrandina G; Martelli O; Rughetti A; Nuti M; Cortesi E; Scambia G
Cancer Immunol Immunother; 2001 Feb; 49(12):641-8. PubMed ID: 11258790
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.
van der Wall E; Richel DJ; Holtkamp MJ; Slaper-Cortenbach IC; van der Schoot CE; Dalesio O; Nooijen WJ; Schornagel JH; Rodenhuis S
Ann Oncol; 1994 Nov; 5(9):795-802. PubMed ID: 7531486
[TBL] [Abstract][Full Text] [Related]
9. Serum G-CSF levels in patients undergoing G-CSF/chemotherapy mobilized peripheral stem cell harvest and predictors of neutrophil and platelet recovery.
Maharaj D; Gómez-Marín O; Lewis-Ximenez LL; Riley R; Albarracín C
Leukemia; 1995 Oct; 9 Suppl 1():S113-7. PubMed ID: 7475301
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.
Eksioglu EA; Kielbasa J; Eisen S; Reddy V
Cytotherapy; 2011 Aug; 13(7):888-96. PubMed ID: 21609205
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
Ho AD; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham RE
Leukemia; 1993 Nov; 7(11):1738-46. PubMed ID: 7901454
[TBL] [Abstract][Full Text] [Related]
12. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer.
Setti M; Bignardi D; Ballestrero A; Ferrando F; Musselli C; Blanchi S; Basso M; Bosco O; Balleari E; Patrone F; Indiveri F
Cancer Immunol Immunother; 1999 Sep; 48(6):287-96. PubMed ID: 10473803
[TBL] [Abstract][Full Text] [Related]
13. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
16. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Kritz A; Crown JP; Motzer RJ; Reich LM; Heller G; Moore MP; Hamilton N; Yao TJ; Heelan RT; Schneider JG
Cancer; 1993 Apr; 71(8):2515-21. PubMed ID: 8095854
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
18. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma.
Ho AD; Haas R; Wulf G; Knauf W; Ehrhardt R; Heilig B; Körbling M; Schulz G; Hunstein W
Blood; 1990 Jan; 75(1):203-12. PubMed ID: 2104762
[TBL] [Abstract][Full Text] [Related]
19. Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer.
Somlo G; Sniecinski I; Odom-Maryon T; Nowicki B; Chow W; Hamasaki V; Leong L; Margolin K; Morgan R; Raschko J; Shibata S; Tetef M; Molina A; Berenson RJ; Forman SJ; Doroshow JH
Blood; 1997 Mar; 89(5):1521-8. PubMed ID: 9057632
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
Elkordy M; Crump M; Vredenburgh JJ; Petros WP; Hussein A; Rubin P; Ross M; Gilbert C; Modlin C; Meisenberg B; Coniglio D; Rabinowitz J; Laughlin M; Kurtzberg J; Peters WP
Bone Marrow Transplant; 1997 Feb; 19(4):315-22. PubMed ID: 9051240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
